AzTrials
AzTrials

Hearing ImpairmentI-ACENCT05815667

Effects of the Swedish Internet-based Individualised Active Communication Education (I-ACE) in FTU

A study testing Individualised Active Communication Education (I-ACE) in people with Hearing Impairment, run by Horselvarden Region Ostergotland at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hearing impairment affects the ability to communicate, which can adversely affect both mental and physical health. The most common used rehabilitation method in hearing impairment is hearing aid fitting. Even with optimally fitted hearing aids, many struggle to hear in situations with difficult listening conditions. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Hearing Impairment
What is being tested?
Individualised Active Communication Education (I-ACE)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
63 participants
Where
1 siteSweden
Study dates
1 Mar 2023to 16 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults >20 years old who have been fitted with hearing aids for the first time (first time users) 6 - 12 months prior.
  • Computer experience and access to computer, tablet and/or smartphone with internet access.
  • Access to BankID or equivalent.

Who cannot join

  • Those who have participated in Active Communication Education prior.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Hörselvården Region Östergötland

    Linköping

Other trials in Sweden

About this study

Official title: Effects of the Swedish Internet-based Individualised Active Communication Education (I-ACE) in First Time Hearing Aid Users: a Randomised Controlled Trial.

Hearing impairment affects the ability to communicate, which can adversely affect both mental and physical health. The most common used rehabilitation method in hearing impairment is hearing aid fitting. Even with optimally fitted hearing aids, many struggle to hear in situations with difficult listening conditions. Active Communication Education (ACE) is an interactive group rehabilitation programme aiming to help those with hearing loss communicate more effectively using communication strategies to cope better in everyday life. An Individualised Active Communication Education (I-ACE) distributed digitally could enable those unable to get to the hearing care facility, or don't want to join the group sessions to benefit from the programme.

This project aims to investigate the effects of the swedish digital version of the I-ACE in first time hearing aid users.

Being tested
Individualised Active Communication Education (I-ACE)
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individualised Active Communication Education (I-ACE)Behavioural

    The swedish I-ACE consists of five modules with different themes, all with sections of information alternated with reflective tasks. The participants are assigned one module each week and provided with weekly feedback from a health care professional on their work, before being assigned the next module.

Study groups in NCT05815667
Study groupRoleWhat they receive
Intervention groupExperimentalI-ACE. All participants are offered the I-ACE programme for the duration of 5 weeks.
Receives: Behavioral: Individualised Active Communication Education (I-ACE)
Control groupNo interventionWaiting list.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Communication and Acceptance Scale (CAS)

    Assessing changes in use of communication strategies and the emotional consequences, knowledge and acceptance of hearing loss.

    Minimum 18 points to maximum 90. Higher score indicates a lower impact of the hearing loss.

    Measured: Baseline, directly post intervention and 6 months post intervention.

Secondary outcomes (4)
  1. Communication Strategies Scale (CSS)

    Assessing changes in use of verbal, non-verbal and maladaptive communication strategies.

    Minimum 25 points to maximum 100. Higher score indicates a greater use of communication strategies.

    Measured: Baseline, directly post intervention and 6 months post intervention.

  2. The Hearing Handicap Inventory for the Elderly (HHIE)

    Assessing changes in emotional and social effects of hearing loss. Minimum 0 points to maximum 100 points. Higher score indicates greater emotional and social effects of hearing loss.

    Measured: Baseline, directly post intervention and 6 months post intervention.

  3. The International Outcome Inventory for Hearing Aids (IOI-HA)

    Assessing changes in perceived effectiveness and satisfaction with hearing aids.

    Minimum 7 points to maximum 35 points. Higher score indicates higher perceived effect.

    Measured: Baseline, directly post intervention and 6 months post intervention.

  4. The International Outcome Inventory for Alternative Interventions (IOI-AI)

    Assessing changes in perceived effectiveness with an alternative intervention, in this case the I-ACE.

    Minimum 7 points to maximum 35 points. Higher score indicates higher perceived effect.

    Measured: Directly post intervention and 6 months post intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2023
  2. Study start1 Mar 2023
  3. Primary completion16 Dec 2023
  4. Study completion16 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
63 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05815667
Sponsor's protocol ID
IAK RCT
Acronym
I-ACE
Status last verified
Feb 2025
First submitted
21 Mar 2023
Last updated
6 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Individualised Active Communication Education (I-ACE) in people with Hearing Impairment, run by Horselvarden Region Ostergotland at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Communication and Acceptance Scale (CAS) (time frame: Baseline, directly post intervention and 6 months post intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in